Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Other Non Operating Income (2016 - 2025)

Dexcom (DXCM) has disclosed Other Non Operating Income for 11 consecutive years, with $17.7 million as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income fell 20.98% to $17.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $176.6 million through Dec 2025, up 62.02% year-over-year, with the annual reading at $176.6 million for FY2025, 62.02% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $17.7 million at Dexcom, down from $109.8 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $109.8 million in Q3 2025, with the low at -$8.3 million in Q4 2021.
  • Average Other Non Operating Income over 5 years is $19.9 million, with a median of $19.2 million recorded in 2025.
  • The sharpest move saw Other Non Operating Income crashed 900.0% in 2022, then skyrocketed 2784.62% in 2023.
  • Over 5 years, Other Non Operating Income stood at -$8.3 million in 2021, then surged by 196.39% to $8.0 million in 2022, then surged by 266.25% to $29.3 million in 2023, then decreased by 23.55% to $22.4 million in 2024, then decreased by 20.98% to $17.7 million in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $17.7 million, $109.8 million, and $28.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.